Here we determined the role of anti-apoptotic Bcl-2 proteins as effectors of bone marrow stroma-mediated drug resistance in AML blasts and the CD34+/CD38− cells representing a population enriched for leukemic stem cells (LSC)19. The gene discussed is CD34; the disease is acute myeloid leukemia.